Press release
Congestive Heart Failure (CHF) Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Congestive Heart Failure CHFMarket Size
The escalating number of individuals suffering from heart- and vessel-related conditions is projected to boost the expansion of the congestive heart failure (CHF) market in the future. The term cardiovascular encompasses the heart and blood vessels' functions, highlighting their significance in blood circulation and the upkeep of overall health. The surge in cardiovascular patients can be attributed to inactive lifestyles, improper diets, aging societies, and urbanization, resulting in an increased demand for sophisticated healthcare and treatment options. Congestive heart failure (CHF) benefits cardiovascular patients by offering customized solutions that enhance heart function, ease symptoms, and thwart complications, ultimately boosting patient healthcare and general wellness. For example, the American College of Cardiology, a non-profit medical society based in the USA, reported a climb to 19.8 million cardiovascular disease cases in 2022 in January 2023. Moreover, Eastern Europe tops the mortality rate chart with 553 deaths per 100,000. Thus, the rising number of cardiovascular patients is fuelling the growth of the congestive heart failure (CHF) market.
Get Your Congestive Heart Failure (CHF) Market Report Here:
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report
What is the future CAGR of the congestive heart failure (chf) market, and how will it impact industry expansion?
The market for congestive heart failure (CHF) has seen robust expansion in recent times. The market, which stood at $15.94 billion in 2024, is projected to enhance to $17.10 billion in 2025, recording a compound annual growth rate (CAGR) of 7.2%. The remarkable growth observed in the past years can be ascribed to factors such as a growing elderly population, increased rates of cardiovascular diseases, surged awareness around cardiac wellness, a spurt in healthcare spending, and the rising demand for remote patient monitoring.
The market for congestive heart failure (CHF) is predicted to witness significant expansion in the forthcoming years, achieving a worth of $22.31 billion in 2029, with a compound annual growth rate (CAGR) of 6.9%. The escalation during the prediction phase is attributed to the escalating acceptance of digital health solutions, the escalating prevalence of hypertension, increasing obesity, enhanced patient results, and a heightened focus on personalized medicine. The major trends during the prediction period encompass breakthroughs in diagnostic technology, innovations in treatment alternatives, technological advancements in imaging, innovation in therapeutic strategies, and progress in wearable health instruments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp
What are the most significant trends transforming the congestive heart failure (chf) market today?
Leading companies in the congestive heart failure (CHF) market are turning their attention to pioneering developments like single intracoronary infusion treatments. These are set to provide better therapeutic outcomes and enhance life quality for those living with CHF. The treatment involves a direct delivery of drugs into the coronary artery, administering accurate treatments for conditions such as CHF. A notable example is the collaboration between Bayer AG, a pharmaceutical company from Germany, and Asklepios Biopharmaceutical, Inc., a biotech firm from the US. In January 2024, they launched the GenePHIT Phase II trial of AB-1002, an experimental gene therapy for CHF. This new treatment leverages a gene therapy strategy to target non-ischemic cardiomyopathy, potentially heralding a game-changing advance in CHF treatment with sophisticated genetic solutions. The trial is designed to be adaptive, double-blind, and placebo-controlled, recruiting 90 to 150 participants who have maintained medical stability for a minimum of four weeks, with a left ventricular ejection fraction ranging from 15% to 35%.
Which key market segments comprise the congestive heart failure (chf) market and drive its revenue growth?
The congestive heart failure (CHF) market covered in this report is segmented -
1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20730
What regions are at the forefront of congestive heart failure (chf) market expansion?
North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure (CHF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the congestive heart failure (chf) market?
Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20730&type=smp
What Is Covered In The Congestive Heart Failure (CHF) Global Market Report?
•Market Size Forecast: Examine the congestive heart failure (chf) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the congestive heart failure (chf) market for a structured understanding.
•Key Players Overview: Analyze major players in the congestive heart failure (chf) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the congestive heart failure (chf) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the congestive heart failure (chf) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the congestive heart failure (chf) market.
•Industry Challenges: Identify potential risks and obstacles affecting the congestive heart failure (chf) market.
•Competitive Landscape: Review strategic developments in the congestive heart failure (chf) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Congestive Heart Failure (CHF) Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3944649 • Views: …
More Releases from The Business Research Company
Global Double-Sided Masking Tapes Market Expansion at 7.8% CAGR, Valued at $18.4 …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Double-Sided Masking Tapes Market Size Forecast for 2025?
The market size of double-sided masking tapes has been experiencing consistent growth in recent years. The market will increase from a figure of $13.01 billion in 2024 to about $13.64 billion in 2025, demonstrating a compound annual growth rate…
Construction Adhesives Market on Path to Hit $18.32 Billion by 2029 at 9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Construction Adhesives Market Outlook: What Size And CAGR Are Anticipated By 2025?
There has been a robust growth in the size of the construction adhesives market in the recent past. The market that was at $12.06 billion in 2024 is projected to rise to $12.95 billion in 2025, with a…
Future of Chromatography Resins Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Chromatography Resins Market by 2025?
In recent years, the market size of chromatography resins has experienced significant growth. Starting from a value of $2.95 billion in 2024, it is predicted to increase to $3.15 billion in 2025 with a compound annual growth…
Blow-Molded Plastics Industry Set to Achieve $128.73 Billion Milestone by 2029 | …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Blow-Molded Plastics Market Size 2025?
The market size of blow-molded plastics has seen constant enlargement in the previous few years. It is expected to rise from $97.17 billion in 2024 to $99.31 billion in 2025, at a compound annual growth rate (CAGR) of…
More Releases for CHF
Work-ID AG: Tackling the Skills Shortage with CHF 4 Million and Skills-Manager
Thalwil, June 25, 2025 - Work-ID AG has closed a successful CHF 4 million financing round. The Thalwil-based start-up is launching Skills-Manager, a tool that shows companies which people fit both professionally and personally. Selecting by age, appearance, or gender? That was yesterday. Skills are the hard currency for smart companies.
Skills-Manager reveals who is a real fit
With Skills-Manager, companies gain a tool to identify and leverage people's skills. They can…
Global Congestive Heart Failure (CHF) Market Outlook 2025-2034: Trends, Innovati …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Congestive Heart Failure (CHF) Market Size and Projected Growth Rate?
The market scope for congestive heart failure (CHF) has seen robust augmentation in the past few years. The growth metrics show a burgeoning move from $15.94 billion in 2024 to $17.10 billion in 2025 with a compound annual growth rate (CAGR)…
Urgent Fundraising Campaign Launched to Pay CHF 4,000 Customs Fee and Reunite Mi …
Image: https://www.abnewswire.com/upload/2025/06/d380113ce38324782cf09e3032c4c76d.jpg
An urgent fundraising campaign has been launched by Miriam Schenk, a local resident facing a critical financial hurdle. With a CHF 4,000 customs bill standing between her and a package from her partner, a career soldier in the U.S. Army, Schenk is calling on kind-hearted donors, supporters, and philanthropists for assistance.
The package, sent by her boyfriend who is currently deployed, contains irreplaceable items of both emotional and financial value.…
Congestive Heart Failure (CHF) Treatment Devices Market Revenue Sizing Outlook A …
Allied Market Research added new research on Global Congestive Heart Failure (CHF) Treatment Devices Market- Global Opportunity Analysis and Industry Forecast, 2022-2030. The Congestive Heart Failure (CHF) Treatment Devices market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key…
Chronic Heart Failure (CHF) Drugs Industry Outlook and Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Chronic Heart Failure (CHF) Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Chronic Heart Failure (CHF) Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH has lately published a new report titled, *Global Chronic Heart Failure (CHF) Drugs Market 2020 by Manufacturers, Regions,…
Screening Eagle raises CHF 55 million to protect the built world
Screening Eagle Technologies (SET), a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, is pleased to announce it has raised CHF 55 million in its first institutional round of equity funding.
Switzerland - April 3, 2020 -- Screening Eagle is on a mission to protect the built world. Massive economic value is at risk from aging global infrastructure and construction birth defects in…
